
Loading, please wait...

Loading, please wait...

The Uni-leaflet mitral valve (ULMV) represents an exceptionally rare congenital cardiac anomaly. Historically, clinicians considered this condition incompatible with long-term survival. However, recent advances in diagnostic imaging have led to more frequent identifications in adult patients. A systematic review of adult cases highlights that this condition demonstrates significant clinical and anatomical diversity. Understanding these variations is essential for providing effective care to affected individuals.
Most adults with this anomaly present with symptoms like dyspnea or heart failure. Research shows that posterior leaflet hypoplasia or agenesis occurs in approximately 97.5% of cases. Consequently, over half of these patients suffer from moderate or greater mitral regurgitation. Furthermore, comorbid conditions such as atrial fibrillation and atrial septal defects are common. Physicians must carefully evaluate these associated anomalies to optimize patient outcomes.
Transthoracic echocardiography serves as the universal tool for initial diagnosis. Meanwhile, transesophageal and three-dimensional imaging offer incremental details regarding the valve's unique anatomy. Regarding treatment, approximately one-third of adult patients require surgical intervention. This typically involves either mitral valve repair or replacement. Fortunately, outcomes for these interventions are generally favorable when tailored to the specific anatomical spectrum of the patient.
The clinical heterogeneity of ULMV suggests it represents a developmental spectrum rather than a single fixed entity. Therefore, experts emphasize the need for standardized definitions across the medical community. Prospective registries will also play a vital role in improving risk stratification. Such data will eventually guide clinicians in refining management protocols for this rare but significant valve disorder.
Most symptomatic adults experience dyspnea, palpitations, or signs of heart failure. These symptoms often stem from significant mitral regurgitation or associated arrhythmias like atrial fibrillation.
Diagnosis begins with transthoracic echocardiography to assess valve structure. However, specialists often use 3D transesophageal echocardiography to obtain precise anatomical details necessary for planning surgical interventions.
Not necessarily. While about one-third of patients undergo valve repair or replacement, others may be managed conservatively. The decision depends on the severity of regurgitation and the presence of symptoms.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A systematic review characterizing the clinical presentation, anatomy, and management of adult patients with rare uni-leaflet mitral valve (ULMV) anomaly....
6 months ago

A recent study demonstrates that spinal oxygen sensors do not require mitochondrial electron transport to trigger sympathetic excitation during acute hypoxia, revealing new insights into how mitochondrial oxidative stress modulates autonomic tone in cardiovascular and neurological diseases.
Today

Demanding exhaustive hormonal profiling can inadvertently discourage clinical studies involving females. Methodological standards must align with the specific scientific question to expand, not restrict, equitable evidence for women.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

A novel calcium polyphosphate coacervate enables injectable bone implants with in situ hierarchical porosity via phase separation and gas foaming, significantly enhancing cell proliferation, energy metabolism, and osteogenic differentiation for minimally invasive bone defect repair.
Today

Following regulatory scrutiny from FSSAI regarding promotional representations and lean muscle preservation claims, Dr. Reddy's Laboratories and Nestlé Health Science are currently reviewing the branding and marketing strategy for their joint nutritional supplement Celevida GLP+.
Today